MTOR and esophageal squamous cell carcinoma: The mTOR inhibitor everolimus and its analogs are used to treat various solid tumors, such as esophageal squamous cell carcinoma, lung cancer, renal cell carcinoma, and prostate cancer [13,14,15,16].